Patents by Inventor Lars Lilljequist

Lars Lilljequist has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • NOVEL PROCESS FOR MAKING (2R)-(3-AMINO-2-FLUOROPROPYL)PHOSPHINIC ACID FORM A
    Publication number: 20110054216
    Abstract: The present invention is directed to a novel process for the preparation of the crystalline form A of (2R)-(3-amino-2-fluoropropyl)phosphinic acid.
    Type: Application
    Filed: December 18, 2008
    Publication date: March 3, 2011
    Inventors: Hassan Abbasi, Daniel Finnhult, Ann-Sofie Krig, Lars Lilljequist, Karin Lundblad, Mikaela Recknagel, Anna Stenemyr, Erica Tjerneld
  • Crystalline forms of 2,3-dimethyl-8-(2,6-dimethylbenzylamino)-N-hydroxyethyl-imidazo[1,2-a] pyridine-6-carboxamide mesylate salt
    Patent number: 7459463
    Abstract: The present invention relates to novel crystalline forms of 2,3-dimethyl-8-(2,6 -dimethylbenzylamino)-N-hydroxyethyl-imidazo[1,2-a]pyridine-6-carboxamide mesylate salt and to mixture thereof. Further, the present invention also relates to processes for obtaining them, the use of said compounds for the treatment of gastrointestinal disorders, and pharmaceutical compositions containing them.
    Type: Grant
    Filed: December 16, 2004
    Date of Patent: December 2, 2008
    Assignee: AstraZeneca AB
    Inventors: Lars Lilljequist, Maria Lindkvist, Peter Nordberg, Ursula Pettersson, Tesfai Sebhatu
  • Novel crystalline forms of 2,3-dimethyl-8-(2,6-dimethylbenzylamino)-n-hydroxyethyl- imidazo [1,2-a] pyridine-6-carboxamide mesylate salt
    Publication number: 20070112021
    Abstract: The present invention relates to novel crystalline forms of 2,3-dimethyl-8-(2,6-dimethylbenzylamino)-N-hydroxyethyl-imidazo[1,2-a]pyridine-6-carboxamide mesylate salt and to mixture thereof. Further, the present invention also relates to processes for obtaining them, the use of said compounds for the treatment of gastrointestinal disorders, and pharmaceutical compositions containing them.
    Type: Application
    Filed: December 16, 2004
    Publication date: May 17, 2007
    Applicant: TRAZENECA AB
    Inventors: Lars Lilljequist, Maria Lindkvist, Peter Nordberg, Ursula Pettersson, Tesfai Sebhatu